Study Summary
This trial will test whether an immersive digital reality system can help reduce the occurrence of delirium in ICU patients.
Treatment Effectiveness
Effectiveness Progress
Study Objectives
3 Primary · 6 Secondary · Reporting Duration: Daily up to 14 days
Day 14
DREAMS usability and acceptability questionnaire
Day 14
Subject's quality of sleep
Day 7
Amount of sedatives requested by subjects
Amount of sedatives subjects receive
Respiratory Rate
Day 7
Assessment of anxiety measured by Hospital Anxiety and Depression Scale (HADS) questionnaire
Day 7
Blood Pressure -Systolic
Heart Rate
Patient pain perception
Trial Safety
Safety Progress
Trial Design
1 Treatment Group
Mediation and Relaxation Intervention
1 of 1
Experimental Treatment
100 Total Participants · 1 Treatment Group
Primary Treatment: Technology based guided meditation and relaxation · No Placebo Group · N/A
Mediation and Relaxation Intervention
Device
Experimental Group · 1 Intervention: Technology based guided meditation and relaxation · Intervention Types: DeviceTrial Logistics
Trial Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: daily up to 14 days
Who is running the clinical trial?
University of FloridaLead Sponsor
1,249 Previous Clinical Trials
698,593 Total Patients Enrolled
5 Trials studying Delirium
722 Patients Enrolled for Delirium
Azra Bihorac, MDPrincipal InvestigatorUniversity of Florida
5 Previous Clinical Trials
828 Total Patients Enrolled
2 Trials studying Delirium
330 Patients Enrolled for Delirium
Eligibility Criteria
Age 18+ · All Participants · 1 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Conditions
Cancer Related
Treatments